,PAR1 -506/

Bettina Langhans1,2, Sandra Kalthoff1, Taotao Zhou1

  • 1Department of Internal Medicine I, University Hospital of Bonn, Bonn, Germany.

概括

蛋白酶激活受体1 (PAR1) -506 Ins等位基因在原发性硬化性胆道炎 (PSC) 患者中更为常见. PAR1 -506 具有PSC的Ins等位基载体可能会经历更短的无移植存活期,这表明PAR1可能会出现更短的无移植存活期.